|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
Quinacrine hydrochloride
|
MedKoo Code#: 202385
|
|
Name: Quinacrine hydrochloride
|
|
CAS#: 69-05-6
Synonym:
atabrine dihydrochloride; mepacrine dihydrochoride; Code name:
SN 390
Chemical structure name: 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine
dihydrochloride.
IUPAC/Chemical name:
N4-(6-chloro-2-methoxyacridin-9-yl)-N1,N1-diethylpentane-1,4-diamine
dihydrochloride
|
|
Chemical structure |
Theoretical analysis
|
|

|
Quinacrine:
Chemical Formula: C23H30ClN3O
Exact Mass: 399.20774
Molecular Weight: 399.96
m/z: 399.20774 (100.0%), 401.20479 (32.0%),
400.21110 (24.9%), 402.20815 (8.0%), 401.21445 (3.0%), 400.20478
(1.1%)
Elemental Analysis: C, 69.07; H, 7.56; Cl,
8.86; N, 10.51; O, 4.00
Quinacrine hydrochloride:
Chemical Formula: C23H32Cl3N3O
Molecular Weight: 472.88
Elemental Analysis: C, 58.42; H, 6.82; Cl,
22.49; N, 8.89; O, 3.38
|
|
Availability and price:
This agent is not in stock, which may be available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Information about this agent
|
Quinacrine dihydrochloride is
the dihydrochloride salt of the 9-aminoacridine derivative
quinacrine with potential antineoplastic and antiparasitic activities.
Quinacrine may inhibit the transcription and activity of both basal and
inducible nuclear factor-kappaB (NF-kappaB), which may result in the
induction of tumor suppressor p53 transcription, the restoration of
p53-dependent apoptotic pathways, and tumor cell apoptosis. Continuous
NF-kappaB signaling, present in many tumors and in chronic inflammatory
processes, promotes the expression of antiapoptotic proteins and
cytokines while downregulating the expression of proapoptotic proteins,
such as p53. Check for
active clinical trials or
closed clinical trials using this agent. (NCI
Thesaurus) .
Quinacrine (trade name Atabrine) is a drug with a
number of different medical applications. It is related to mefloquine.
Medical application
(This section was directly from
http://en.wikipedia.org/wiki/Quinacrine)
Its main effects are as an antiprotozoal,
antirheumatic and an intrapleural sclerosing agent. Antiprotozoal use
include targeting Giardiasis, where quinacrine is indicated as a primary
agent for patients with metronidazole-resistant giardiasis and patients
who should not receive or can not tolerate metronidazole. Giardiasis
that is very resistant may even require a combination of quinacrine and
metronidazole. Quinacrine is also used "off-label" for the treatment of
systemic lupus erythematosus, indicated in the treatment of
discoid and subcutaneous lupus erythematosus, particularly in patients
unable to take chloroquine derivatives. As an intrapleural sclerosing
agent, it is used as pneumothorax prophylaxis in patients at high risk
of recurrence, e.g., cystic fibrosis patients. Quinacrine is not the
drug of choice because side effects are common, including toxic
psychosis, and may cause permanent damage. View Mefloquine page for more
information.
History of uses as medicine
(This section was directly from
http://en.wikipedia.org/wiki/Quinacrine)
Antiprotozoal: Quinacrine was
initially approved in the 1930s as an antimalarial drug. This
antiprotozoal is also approved for the treatment of Giardiasis (an
intestinal parasite)[3], and has been researched as an inhibitor of
phospholipase A2. Scientists at Bayer in Germany first synthesised
Quinacrine in 1931 and subsequently marketed as Mepacrine or Atebrine.
The product was one of the first synthetic substitutes for quinine
although later superseded by chloroquine.
Anthelmintics: In addition it has
been used for treating tapeworm infections.
Creutzfeldt-Jakob disease:
Quinacrine has been shown to bind to the prion protein and prevent the
formation of prion aggregates in vitro, and full clinical trials of its
use as a treatment for Creutzfeldt-Jakob disease are under way in the
United Kingdom and the United States. Small trials in Japan have
reported improvement in the condition of patients with the disease,
although other reports have shown no significant effect, and
treatment of scrapie in mice and sheep has also shown no effect.
Possible reasons for the lack of an in-vivo effect include inefficient
penetration of the blood brain barrier, as well as the existence of
drug-resistant prion proteins that increase in number when selected for
by treatment with quinacrine.
Quinacrine non-surgical sterilization for women (QS):
The use of quinacrine for non-surgical sterilization for women has also
been researched. This method , was developed by Zipper et al. who
reported a first year failure rate of 3.1%. However, despite a multitude
clinical studies on the use of quinacrine and female sterilization, no
randomized, controlled trials have been reported to date and there is
some controversy over its use. Pellets of quinacrine are inserted
through the cervix into a woman's uterine cavity using a preloaded
inserter device, similar in manner to IUCD insertion. The procedure is
undertaken twice, first in the proliferative phase, 6 to 12 days
following the first day of the menstrual cycle and again one month
later. The sclerosing effects of the drugs at the utero-tubal junctions
(where the Fallopian tubes enter the uterus) results in scar tissue
forming over a six week interval to close off the tubes permanently.
Current developer:
1: Gasparian AV, Neznanov N, Jha S, Galkin O,
Moran JJ, Gudkov AV, Gurova KV, Komar AA. Inhibition of EMCV and
poliovirus replication by quinacrine: implications for the design and
discovery of novel anti-viral drugs. J Virol. 2010 Jul 14. [Epub ahead
of print] PubMed PMID: 20631142.
2: Jani TS, DeVecchio J, Mazumdar T, Agyeman A, Houghton JA. Inhibition
of NF-kappaB signaling by quinacrine is cytotoxic to human colon
carcinoma cell lines and is synergistic in combination with tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
J Biol Chem. 2010 Jun 18;285(25):19162-72. Epub 2010 Apr 27. PubMed
PMID: 20424169; PubMed Central PMCID: PMC2885195.
3: Wang Y, Bi Q, Dong L, Li X, Ge X, Zhang X, Fu J, Wu D, Li S.
Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell
lines. Chemotherapy. 2010;56(2):127-34. Epub 2010 Apr 20. PubMed PMID:
20407239.
4: Geng Y, Kohli L, Klocke BJ, Roth KA. Chloroquine-induced autophagic
vacuole accumulation and cell death in glioma cells is p53 independent.
Neuro Oncol. 2010 May;12(5):473-81. Epub 2010 Jan 27. PubMed PMID:
20406898.
5: Sokal DC, Vach TH, Nanda K, McCann MF, Weiner DH, Drobnes C,
Rochanawutanon M, Duc NB, Loan ND. Quinacrine sterilization and
gynecologic cancers: a case-control study in northern Vietnam.
Epidemiology. 2010 Mar;21(2):164-71. PubMed PMID: 20160560.
6: McConnell EE, Lippes J, Growe RG, Fail P, Luster MI, Zeiger E. An
alternative interpretation of, "A lifetime cancer bioassay of quinacrine
administered into the uterine horns of female rats". Regul Toxicol
Pharmacol. 2010 Mar;56(2):166-73. Epub 2010 Jan 4. PubMed PMID:
20043971.
7: Sokal DC, Trujillo V, Guzmán SC, Guzman-Serani R, Wheeless A,
Hubacher D. Cancer risk after sterilization with transcervical
quinacrine: updated findings from a Chilean cohort. Contraception. 2010
Jan;81(1):75-8. Epub . PubMed PMID: 20004277.
8: Gurova K. New hopes from old drugs: revisiting DNA-binding small
molecules as anticancer agents. Future Oncol. 2009 Dec;5(10):1685-704.
Review. PubMed PMID: 20001804; PubMed Central PMCID: PMC2821823.
9: Chau CH, Figg WD. New tricks from an old drug: a role for quinacrine
in anti-cancer therapy? Cell Cycle. 2009 Dec 15;8(24):4024-5. Epub 2009
Dec 15. PubMed PMID: 19959937.
10: Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, DeArmond SJ,
Prusiner SB. Continuous quinacrine treatment results in the formation of
drug-resistant prions. PLoS Pathog. 2009 Nov;5(11):e1000673. Epub 2009
Nov 26. PubMed PMID: 19956709; PubMed Central PMCID: PMC2777304.
11: Neznanov N, Gorbachev AV, Neznanova L, Komarov AP, Gurova KV,
Gasparian AV, Banerjee AK, Almasan A, Fairchild RL, Gudkov AV.
Anti-malaria drug blocks proteotoxic stress response: anti-cancer
implications. Cell Cycle. 2009 Dec;8(23):3960-70. Epub 2009 Dec 25.
PubMed PMID: 19901558.
12: Cancel AM, Dillberger JE, Kelly CM, Bolte HF, Creasy DM, Sokal DC. A
lifetime cancer bioassay of quinacrine administered into the uterine
horns of female rats. Regul Toxicol Pharmacol. 2010 Mar;56(2):156-65.
Epub 2009 Jul 23. PubMed PMID: 19631709.
13: Wong IL, Chan KF, Zhao Y, Chan TH, Chow LM. Quinacrine and a novel
apigenin dimer can synergistically increase the pentamidine
susceptibility of the protozoan parasite Leishmania. J Antimicrob
Chemother. 2009 Jun;63(6):1179-90. Epub 2009 Apr 17. PubMed PMID:
19377065.
14: Guo C, Gasparian AV, Zhuang Z, Bosykh DA, Komar AA, Gudkov AV,
Gurova KV. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR,
NF-kappaB and p53 pathways. Oncogene. 2009 Feb 26;28(8):1151-61. Epub
2009 Jan 12. PubMed PMID: 19137016.
15: Rossi T, Coppi A, Bruni E, Ruberto A, Giudice S, Baggio G. Mepacrine
antagonises tumour cell growth induced by natural polyamines. Anticancer
Res. 2008 Sep-Oct;28(5A):2765-8. PubMed PMID: 19035307.
16: Liang GW, Lu WL, Wu JW, Zhao JH, Hong HY, Long C, Li T, Zhang YT,
Zhang H, Wang JC, Zhang X, Zhang Q. Enhanced therapeutic effects on the
multi-drug resistant human leukemia cells in vitro and xenograft in mice
using the stealthy liposomal vincristine plus quinacrine. Fundam Clin
Pharmacol. 2008 Aug;22(4):429-37. PubMed PMID: 18705753.
17: Lipka D, Boratyński J. [Metalloproteinases. Structure and function].
Postepy Hig Med Dosw (Online). 2008 Jul 3;62:328-36. Review. Polish.
PubMed PMID: 18614970.
18: Sokal DC, Hieu do T, Loan ND, Hubacher D, Nanda K, Weiner DH, Vach
TH. Safety of quinacrine contraceptive pellets: results from 10-year
follow-up in Vietnam. Contraception. 2008 Jul;78(1):66-72. Epub 2008 Apr
16. PubMed PMID: 18555820.
19: Sun S, Rao NL, Venable J, Thurmond R, Karlsson L. TLR7/9 antagonists
as therapeutics for immune-mediated inflammatory disorders. Inflamm
Allergy Drug Targets. 2007 Dec;6(4):223-35. Review. PubMed PMID:
18220957.
20: Markaverich BM, Crowley J, Rodriquez M, Shoulars K, Thompson T.
Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and
cyclooxygenase gene expression and MCF-7 human breast cancer cell
proliferation. Environ Health Perspect. 2007 Dec;115(12):1727-31. PubMed
PMID: 18087590; PubMed Central PMCID: PMC2137134.
21: Fasano C, Campana V, Griffiths B, Kelly G, Schiavo G, Zurzolo C.
Gene expression profile of quinacrine-cured prion-infected mouse
neuronal cells. J Neurochem. 2008 Apr;105(1):239-50. Epub 2007 Nov 25.
PubMed PMID: 18036195.
22: Friedman J, Nottingham L, Duggal P, Pernas FG, Yan B, Yang XP, Chen
Z, Van Waes C. Deficient TP53 expression, function, and cisplatin
sensitivity are restored by quinacrine in head and neck cancer. Clin
Cancer Res. 2007 Nov 15;13(22 Pt 1):6568-78. PubMed PMID: 18006756.
23: Yoshida MA, Nakata A, Akiyama M, Kakinuma S, Sado T, Nishimura M,
Shimada Y. Distinct structural abnormalities of chromosomes 11 and 12
associated with loss of heterozygosity in X-ray-induced mouse thymic
lymphomas. Cancer Genet Cytogenet. 2007 Nov;179(1):1-10. PubMed PMID:
17981208.
24: Rossi T, Coppi A, Bruni E, Ruberto A, Santachiara S, Baggio G.
Effects of anti-malarial drugs on MCF-7 and Vero cell replication.
Anticancer Res. 2007 Jul-Aug;27(4B):2555-9. PubMed PMID: 17695553.
25: Thomas W, Coen N, Faherty S, Flatharta CO, Harvey BJ. Estrogen
induces phospholipase A2 activation through ERK1/2 to mobilize
intracellular calcium in MCF-7 cells. Steroids. 2006 Mar;71(3):256-65.
Epub 2005 Dec 22. PubMed PMID: 16375935.
26: Hassan S, Carraway RE. Involvement of arachidonic acid metabolism
and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth.
Regul Pept. 2006 Jan 15;133(1-3):105-14. Epub 2005 Dec 5. PubMed PMID:
16330112.
27: Duvvuri M, Krise JP. A novel assay reveals that weakly basic model
compounds concentrate in lysosomes to an extent greater than
pH-partitioning theory would predict. Mol Pharm. 2005
Nov-Dec;2(6):440-8. PubMed PMID: 16323951.
28: Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E,
Khodyakova AV, Ganapathi R, Ganapathi M, Tararova ND, Bosykh D, Lvovskiy
D, Webb TR, Stark GR, Gudkov AV. Small molecules that reactivate p53 in
renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53
suppression in tumors. Proc Natl Acad Sci U S A. 2005 Nov
29;102(48):17448-53. Epub 2005 Nov 15. PubMed PMID: 16287968; PubMed
Central PMCID: PMC1297696.
29: Wang W, Ho WC, Dicker DT, MacKinnon C, Winkler JD, Marmorstein R,
El-Deiry WS. Acridine derivatives activate p53 and induce tumor cell
death through Bax. Cancer Biol Ther. 2005 Aug;4(8):893-8. PubMed PMID:
16177561.
30: Zhu W, Pan ZZ. Mu-opioid-mediated inhibition of glutamate synaptic
transmission in rat central amygdala neurons. Neuroscience.
2005;133(1):97-103. PubMed PMID: 15893634.
31: Briceño E, Reyes S, Sotelo J. Therapy of glioblastoma multiforme
improved by the antimutagenic chloroquine. Neurosurg Focus. 2003 Feb
15;14(2):e3. PubMed PMID: 15727424.
32: Ukale V, Agrenius V, Widström O, Hassan A, Hillerdal G. Inflammatory
parameters after pleurodesis in recurrent malignant pleural effusions
and their predictive value. Respir Med. 2004 Dec;98(12):1166-72. PubMed
PMID: 15588036.
33: Yoon-yub P, Hybertson B, Wright R, Fini M, Elkins N, Repine J. Serum
ferritin elevation and acute lung injury in rats subjected to
hemorrhage: reduction by mepacrine treatment. Exp Lung Res. 2004
Oct-Nov;30(7):571-84. PubMed PMID: 15371093.
34: Sotelo J, Guevara P, Pineda B, Diaz C. Interstitial quinacrine
activates a distinctive immune response effective for tumor
immunotherapy. Surgery. 2004 Sep;136(3):700-7. PubMed PMID: 15349121.
35: Ukale V, Agrenius V, Hillerdal G, Mohlkert D, Widström O.
Pleurodesis in recurrent pleural effusions: a randomized comparison of a
classical and a currently popular drug. Lung Cancer. 2004
Mar;43(3):323-8. PubMed PMID: 15165091.
36: Kwiek JJ, Haystead TA, Rudolph J. Kinetic mechanism of quinone
oxidoreductase 2 and its inhibition by the antimalarial quinolines.
Biochemistry. 2004 Apr 20;43(15):4538-47. PubMed PMID: 15078100.
37: Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions.
Cochrane Database Syst Rev. 2004;(1):CD002916. Review. PubMed PMID:
14973997.
38: Zipper J, Trujillo V. 25 years of quinacrine sterilization
experience in Chile: review of 2,592 cases. Int J Gynaecol Obstet. 2003
Oct;83 Suppl 2:S23-9. PubMed PMID: 14763182.
39: Murakami-Kubo I, Doh-Ura K, Ishikawa K, Kawatake S, Sasaki K, Kira
J, Ohta S, Iwaki T. Quinoline derivatives are therapeutic candidates for
transmissible spongiform encephalopathies. J Virol. 2004
Feb;78(3):1281-8. PubMed PMID: 14722283; PubMed Central PMCID:
PMC327112.
40: Matsubara Y, Murakami Y, Kobayashi M, Morita Y, Tamiya E.
Application of on-chip cell cultures for the detection of allergic
response. Biosens Bioelectron. 2004 Feb 15;19(7):741-7. PubMed PMID:
14709393.
41: Piosik J, Ulanowska K, Gwizdek-Wiśniewska A, Czyz A, Kapuściński J,
Wegrzyn G. Alleviation of mutagenic effects of polycyclic aromatic
agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and
pentoxifylline. Mutat Res. 2003 Sep 29;530(1-2):47-57. PubMed PMID:
14563530.
42: Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H,
Dormont D, Meijer L, Cullin C, Blondel M. Isolation of drugs active
against mammalian prions using a yeast-based screening assay. Nat
Biotechnol. 2003 Sep;21(9):1075-81. Epub 2003 Aug 10. PubMed PMID:
12910243.
43: Chung JH, Lester RL, Dickson RC. Sphingolipid requirement for
generation of a functional v1 component of the vacuolar ATPase. J Biol
Chem. 2003 Aug 1;278(31):28872-81. Epub 2003 May 13. PubMed PMID:
12746460.
44: de Leval L, Defraigne JO, Hermans G, Dôme F, Boniver J, Herens C.
Malignant solitary fibrous tumor of the pleura: report of a case with
cytogenetic analysis. Virchows Arch. 2003 Apr;442(4):388-92. Epub 2003
Feb 27. PubMed PMID: 12715174.
45: Castaing M, Loiseau A, Djoudi L. Effects of cholesterol on dye
leakage induced by multidrug-resistance modulators from anionic
liposomes. Eur J Pharm Sci. 2003 Jan;18(1):81-8. PubMed PMID: 12554076.
46: Rao M. Quinacrine sterilisations banned. Health Millions. 1998
May-Jun;24(3):14. PubMed PMID: 12293800.
47: Sohn TA, Bansal R, Su GH, Murphy KM, Kern SE. High-throughput
measurement of the Tp53 response to anticancer drugs and random
compounds using a stably integrated Tp53-responsive luciferase reporter.
Carcinogenesis. 2002 Jun;23(6):949-57. Erratum in: Carcinogenesis. 2003
Oct;24(10):1713. PubMed PMID: 12082016.
48: Kapuscinski J, Ardelt B, Piosik J, Zdunek M, Darzynkiewicz Z. The
modulation of the DNA-damaging effect of polycyclic aromatic agents by
xanthines. Part I. Reduction of cytostatic effects of quinacrine mustard
by caffeine. Biochem Pharmacol. 2002 Feb 15;63(4):625-34. PubMed PMID:
11992630.
49: Reyes S, Rembao D, Sotelo J. The antimalarials quinacrine and
chloroquine potentiate the transplacental carcinogenic effect of
ethylnitrosourea on ependymal cells. Brain Tumor Pathol.
2001;18(2):83-7. PubMed PMID: 11908878.
50: Angeles Puertollano M, Algarra I, Ortega E, de Pablo MA, Alvarez de
Cienfuegos G. Loss of natural killer cell activity after murine tumor
transplantation appears as a consequence of dietary lipid
administration. Anticancer Res. 2001 Jul-Aug;21(4A):2697-702. PubMed
PMID: 11724342.
51: Reyes S, Herrera LA, Ostrosky P, Sotelo J. Quinacrine enhances
carmustine therapy of experimental rat glioma. Neurosurgery. 2001
Oct;49(4):969-73. PubMed PMID: 11564260.
52: Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine
derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad
Sci U S A. 2001 Aug 14;98(17):9836-41. PubMed PMID: 11504948; PubMed
Central PMCID: PMC55539.
53: Fasanmade AA, Owuor ED, Ee RP, Qato D, Heller M, Kong AN. Quinacrine
induces cytochrome c-dependent apoptotic signaling in human cervical
carcinoma cells. Arch Pharm Res. 2001 Apr;24(2):126-35. PubMed PMID:
11339632.
54: Ardelt B, Kunicki J, Traganos F, Darzynkiewicz Z. Chlorophyllin
protects cells from the cytostatic and cytotoxic effects of quinacrine
mustard but not of nitrogen mustard. Int J Oncol. 2001 Apr;18(4):849-53.
PubMed PMID: 11251184.
55: Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in
the anaerobic protozoa. Clin Microbiol Rev. 2001 Jan;14(1):150-64.
Review. PubMed PMID: 11148007; PubMed Central PMCID: PMC88967.
56: Sotelo J, Guevara P, Reyes S, Arrieta O. Interstitial quinacrine for
elimination of abnormal tissue; therapy of experimental glioma. Surgery.
2000 Sep;128(3):439-46. PubMed PMID: 10965316.
57: Sokal DC, Dabancens A, Guzman-Serani R, Zipper J. Cancer risk among
women sterilized with transcervical quinacrine in Chile: an update
through 1996. Fertil Steril. 2000 Jul;74(1):169-71. PubMed PMID:
10899517.
58: Gosslau A, Rensing L. Induction of Hsp68 by oxidative stress
involves the lipoxygenase pathway in C6 rat glioma cells. Brain Res.
2000 May 2;864(1):114-23. PubMed PMID: 10793193.
59: Doh-Ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine
protease inhibitors inhibit scrapie-associated prion protein
accumulation. J Virol. 2000 May;74(10):4894-7. PubMed PMID: 10775631;
PubMed Central PMCID: PMC112015.
60: Wang X, Walsh LP, Stocco DM. The role of arachidonic acid on
LH-stimulated steroidogenesis and steroidogenic acute regulatory protein
accumulation in MA-10 mouse Leydig tumor cells. Endocrine. 1999
Feb;10(1):7-12. PubMed PMID: 10403565.
61: Roller A, Bähr OR, Streffer J, Winter S, Heneka M, Deininger M,
Meyermann R, Naumann U, Gulbins E, Weller M. Selective potentiation of
drug cytotoxicity by NSAID in human glioma cells: the role of COX-1 and
MRP. Biochem Biophys Res Commun. 1999 Jun 16;259(3):600-5. PubMed PMID:
10364464.
62: Siese A, Jaros PP, Willig A. Analysis of interleukin (IL)-1 beta and
transforming growth factor (TGF)-beta-induced signal transduction
pathways in IL-2 and TGF-beta secretion and proliferation in the thymoma
cell line EL4.NOB-1. Scand J Immunol. 1999 Feb;49(2):139-48. PubMed
PMID: 10075017.
63: Finley JW. Manganese uptake and release by cultured human hepato-carcinoma
(Hep-G2) cells. Biol Trace Elem Res. 1998 Summer;64(1-3):101-18. PubMed
PMID: 9845466.
64: Kessel E. Quinacrine sterilization: an assessment of risks for
ectopic pregnancy, birth defects and cancer. Adv Contracept. 1998
Jun;14(2):81-90. Review. PubMed PMID: 9820926.
65: Petr MJ, Origitano TC, Wurster RD. PLA2 activity regulates Ca2+
storage-dependent cellular proliferation. Exp Cell Res. 1998 Oct
10;244(1):310-8. PubMed PMID: 9770374.
66: Yoshioka K, Clejan S, Fisher JW. Activation of protein kinase C in
human hepatocellular carcinoma (HEP3B) cells increases erythropoietin
production. Life Sci. 1998;63(7):523-35. PubMed PMID: 9718078.
67: Furukawa F, Nishikawa A, Imazawa T, Kasahara K, Takahashi M.
Enhancing effects of quinacrine on development of hepatopancreatic
lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters. Jpn J
Cancer Res. 1998 Feb;89(2):131-6. PubMed PMID: 9548439.
68: de Souza PL, Castillo M, Myers CE. Enhancement of paclitaxel
activity against hormone-refractory prostate cancer cells in vitro and
in vivo by quinacrine. Br J Cancer. 1997;75(11):1593-600. PubMed PMID:
9184173; PubMed Central PMCID: PMC2223533.
69: Mufti NA, Shuler ML. Possible role of arachidonic acid in
stress-induced cytochrome P450IA1 activity. Biotechnol Prog. 1996
Nov-Dec;12(6):847-54. PubMed PMID: 8983209.
70: Colella G, Bonfanti M, D'Incalci M, Broggini M. Characterization of
a protein recognizing minor groove binders-damaged DNA. Nucleic Acids
Res. 1996 Nov 1;24(21):4227-33. PubMed PMID: 8932377; PubMed Central
PMCID: PMC146256.
71: Castelli M, Baggio G, Ruberto AI, Tampieri A, Tartoni PL, Rossi T,
Bossa MR, Galatulas I. Influence of antimalarials chloroquine, quinine,
primaquine and mepacrine on the evolution of Ehrlich ascites tumour.
Anticancer Res. 1996 Sep-Oct;16(5A):2673-5. PubMed PMID: 8917368.
72: Dunican DJ, Griffiths R, Williams DC, O'Neill LA. Endothelin-1
increases arachidonic acid release in C6 glioma cells through a
potassium-modulated influx of calcium. J Neurochem. 1996
Aug;67(2):830-7. PubMed PMID: 8764613.
73: Jiang MC, Yang-Yen HF, Lin JK, Yen JJ. Differential regulation of
p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by
widely divergent stimuli in human hepatoblastoma cells. Oncogene. 1996
Aug 1;13(3):609-16. PubMed PMID: 8760302.
74: Kessel E. 100,000 quinacrine sterilizations. Adv Contracept. 1996
Jun;12(2):69-76. Review. PubMed PMID: 8863903.
75: Wilson EW. Sterilization. Baillieres Clin Obstet Gynaecol. 1996
Apr;10(1):103-19. Review. PubMed PMID: 8736725.
76: Imaida K. Delayed toxicity associated with morphological changes in
animal experiments. J Toxicol Sci. 1996 Feb;21(1):97-103. PubMed PMID:
8852295.
77: Jiang MC, Yang-Yen HF, Yen JJ, Lin JK. Curcumin induces apoptosis in
immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer.
1996;26(1):111-20. PubMed PMID: 8844727.
78: Tai YH, Flick J, Levine SA, Madara JL, Sharp GW, Donowitz M.
Regulation of tight junction resistance in T84 monolayers by elevation
in intracellular Ca2+: a protein kinase C effect. J Membr Biol. 1996
Jan;149(1):71-9. PubMed PMID: 8825530.
79: Fox G, Popanda O, Edler L, Thielmann HW. Preferential inhibition of
DNA polymerases alpha, delta, and epsilon from Novikoff hepatoma cells
by inhibitors of cell proliferation. J Cancer Res Clin Oncol.
1996;122(2):78-94. PubMed PMID: 8576284.
80: Pajeva IK, Wiese M, Cordes HP, Seydel JK. Membrane interactions of
some catamphiphilic drugs and relation to their
multidrug-resistance-reversing ability. J Cancer Res Clin Oncol.
1996;122(1):27-40. PubMed PMID: 8543589.
81: Zipper J, Dabancens A, Guerrero A, Trujillo V. Quinacrine:
sclerosing agent of the utero-tubal junction in women, with
anticarcinogenic actions in transplanted tumors in mice. Int J Gynaecol
Obstet. 1995 Dec;51 Suppl 1:S47-55. Review. PubMed PMID: 8904515.
82: Bjermer L, Gruber A, Sue-Chu M, Sandström T, Eksborg S, Henriksson
R. Effects of intrapleural mitoxantrone and mepacrine on malignant
pleural effusion--a randomised study. Eur J Cancer. 1995
Dec;31A(13-14):2203-8. PubMed PMID: 8652243.
83: Family Health International FHI. FHI quinacrine studies. Network.
1995 Sep;16(1):27. PubMed PMID: 12290470.
84: Ito H, Hasegawa K, Inaguma Y, Kozawa O, Asano T, Kato K. Modulation
of the stress-induced synthesis of stress proteins by a phorbol ester
and okadaic acid. J Biochem. 1995 Sep;118(3):629-34. PubMed PMID:
8690728.
85: Perregaux DG, Dean D, Cronan M, Connelly P, Gabel CA. Inhibition of
interleukin-1 beta production by SKF86002: evidence of two sites of in
vitro activity and of a time and system dependence. Mol Pharmacol. 1995
Sep;48(3):433-42. PubMed PMID: 7565623.
86: Lee RK, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein
processing is stimulated by metabotropic glutamate receptors. Proc Natl
Acad Sci U S A. 1995 Aug 15;92(17):8083-7. PubMed PMID: 7644542; PubMed
Central PMCID: PMC41291.
87: Dabancens A, Sokal DC, Pruyas M, Rivera M, Zipper J. Prevalence and
standardized incidence rates of preclinical cervical pathology among
1,061 women sterilized with transcervical quinacrine hydrochloride
pellets. Fertil Steril. 1995 Aug;64(2):444-6. PubMed PMID: 7615128.
88: Sokal DC, Zipper J, Guzman-Serani R, Aldrich TE. Cancer risk among
women sterilized with transcervical quinacrine hydrochloride pellets,
1977 to 1991. Fertil Steril. 1995 Aug;64(2):325-34. PubMed PMID:
7615111.
89: Hillerdal G. Pleural malignancies including mesothelioma. Curr Opin
Pulm Med. 1995 Jul;1(4):339-43. Review. PubMed PMID: 9363074.
90: Zipper J, Dabancens A, Guerrero A, Trujillo V. Quinacrine revised.
Hum Reprod Update. 1995 Jul;1(4):324-42. Review. PubMed PMID: 9080211.
91: Kato K, Ito H, Hasegawa K, Inaguma Y, Suzuki A, Kozawa O, Asano T.
Enhancement of stress-induced synthesis of stress proteins by mastoparan
in C6 rat glioma cells. J Biochem. 1995 Jul;118(1):149-53. PubMed PMID:
8537304.
92: Jäättelä M, Benedict M, Tewari M, Shayman JA, Dixit VM. Bcl-x and
Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of
phospholipase A2 in breast carcinoma cells. Oncogene. 1995 Jun
15;10(12):2297-305. PubMed PMID: 7540278.
93: Ray R, Legere RH, Majerus BJ, Petrali JP. Sulfur mustard-induced
increase in intracellular free calcium level and arachidonic acid
release from cell membrane. Toxicol Appl Pharmacol. 1995
Mar;131(1):44-52. PubMed PMID: 7878677.
94: Wada HG, Fok KS, Fendly BM, Chiang NY, Sussman HH. Activation of
TNF-R1 receptor in the presence of copper kills TNF resistant CEM
leukemic T cells. J Cell Physiol. 1994 Dec;161(3):597-605. PubMed PMID:
7962141.
95: Li ZY, Yu TF, Lian EC. Purification and characterization of L-amino
acid oxidase from king cobra (Ophiophagus hannah) venom and its effects
on human platelet aggregation. Toxicon. 1994 Nov;32(11):1349-58. PubMed
PMID: 7886693.
96: Agrenius V, Gustafsson LE, Widström O. Tumour necrosis factor-alpha
and nitric oxide, determined as nitrite, in malignant pleural effusion.
Respir Med. 1994 Nov;88(10):743-8. PubMed PMID: 7846335.
97: Endo S, Metzler M, Hieber L. Nonrandom karyotypic changes in a
spontaneously immortalized and tumourigenic Syrian hamster embryo cell
line. Carcinogenesis. 1994 Oct;15(10):2387-90. PubMed PMID: 7955083.
98: Dabancens A, Zipper J, Guerrero A. Quinacrine and copper, compounds
with anticonceptive and antineoplastic activity. Contraception. 1994
Sep;50(3):243-51. PubMed PMID: 7805375.
99: Blagosklonny MV, Neckers LM. Oligonucleotides protect cells from the
cytotoxicity of several anti-cancer chemotherapeutic drugs. Anticancer
Drugs. 1994 Aug;5(4):437-42. PubMed PMID: 7949248.
100: Wallace DJ. Controversy over sclerotherapy for malignant pleural
effusions. Ann Intern Med. 1994 Jul 15;121(2):151. PubMed PMID: 8017734.
101: FHI's role in search for nonsurgical sterilization. Network. 1994
May;14(4):26-9. PubMed PMID: 12287743.
102: Bourgeois CA, Kokalj-Vokac N, Dutrillaux AM, Poisson M, Delattre
JY, Vega F, Malfoy B, Dutrillaux B. [Characterization of chromosomal
rearrangements by in situ hybridization in glioblastoma]. Bull Cancer.
1994 May;81(5):360-5. French. PubMed PMID: 7538360.
103: Quinacrine pellets have potential for simple, low-cost female
sterilizations. Contracept Technol Update. 1994 Apr;15(4):41-4. PubMed
PMID: 12318749.
104: Luna MC, Wong S, Gomer CJ. Photodynamic therapy mediated induction
of early response genes. Cancer Res. 1994 Mar 1;54(5):1374-80. PubMed
PMID: 8118827.
105: Gebbia N, Mannino R, Di Dino A, Maxhouni L, Bellone N, Cinque L,
Liuzza A, La Motta P, Cannata G, Gulotta G, et al. Intracavitary
treatment of malignant pleural and peritoneal effusions in cancer
patients. Anticancer Res. 1994 Mar-Apr;14(2B):739-45. Review. PubMed
PMID: 7516642.
106: Banerjee AK, Willetts I, Robertson JF, Blamey RW. Pleural effusion
in breast cancer: a review of the Nottingham experience. Eur J Surg
Oncol. 1994 Feb;20(1):33-6. PubMed PMID: 8131866.
107: Dutta P, Karmali R, Pinto JT, Rivlin RS. Enhanced growth of mammary
adenocarcinoma in rats by chloroquine and quinacrine. Cancer Lett. 1994
Jan 30;76(2-3):113-9. PubMed PMID: 8149339.
108: Dabancens A, Pruyas M, Rivera M, Sokal D, Zipper J. [Standardized
rates of incidence and prevalence of cervical preclinical pathology in
1,061 women sterilized with intrauterine quinacrine]. Rev Chil Obstet
Ginecol. 1994;59(3):181-4. Spanish. PubMed PMID: 7659809.
109: Thielmann HW, Popanda O, Gersbach H, Gilberg F. Various inhibitors
of DNA topoisomerases diminish repair-specific DNA incision in
UV-irradiated human fibroblasts. Carcinogenesis. 1993
Nov;14(11):2341-51. PubMed PMID: 8242865.
110: Fabbri S, Prontera C, Broggini M, D'Incalci M. Differential
inhibition of the DNA binding of transcription factors NF kappa B and
OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional
implications. Carcinogenesis. 1993 Sep;14(9):1963-7. PubMed PMID:
8403225.
111: Koldsland S, Svennevig JL, Lehne G, Johnson E. Chemical pleurodesis
in malignant pleural effusions: a randomised prospective study of
mepacrine versus bleomycin. Thorax. 1993 Aug;48(8):790-3. PubMed PMID:
7692617; PubMed Central PMCID: PMC464703.
112: Butcher RD, Wojcik SJ, Lints T, Wilson T, Schofield PC, Ralph R.
Arachidonic acid, a growth signal in murine P815 mastocytoma cells.
Cancer Res. 1993 Jul 15;53(14):3405-10. PubMed PMID: 8391926.
113: New sterilization techniques accent ease, speed. Family Plan World.
1993 Jul-Aug;3(4):29. PubMed PMID: 12288088.
114: Bjøro T, Englund K, Torjesen PA, Haug E. Inhibitors of the
arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated
prolactin production without modifying the production of
inositolphosphates in GH4C1 pituitary cells. Scand J Clin Lab Invest.
1993 Apr;53(2):111-6. PubMed PMID: 8469910.
115: Lynch TJ Jr. Management of malignant pleural effusions. Chest. 1993
Apr;103(4 Suppl):385S-389S. Review. PubMed PMID: 7681744.
116: Marcil J, Ravindranath N, Sairam MR. Cytotoxic activity of
lutropin-gelonin conjugate in mouse Leydig tumor cells: potentiation of
the hormonotoxin activity by different drugs. Mol Cell Endocrinol. 1993
Mar;92(1):83-90. PubMed PMID: 8472871.
117: Agrenius V, Ukale V, Widström O, Källenius G, Svenson SB.
Quinacrine-induced pleural inflammation in malignant pleurisy: relation
between drainage time of pleural fluid and local interleukin-1 beta
levels. Respiration. 1993;60(6):366-72. PubMed PMID: 8290803.
118: Popanda O, Thielmann HW. The function of DNA topoisomerases in
UV-induced DNA excision repair: studies with specific inhibitors in
permeabilized human fibroblasts. Carcinogenesis. 1992 Dec;13(12):2321-8.
PubMed PMID: 1335377.
119: Béhé P, Sandmeier K, Meves H. The effect of arachidonic acid on the
M current of NG108-15 neuroblastoma x glioma hybrid cells. Pflugers
Arch. 1992 Nov;422(2):120-8. PubMed PMID: 1488272.
120: O'Rourke AM, Mescher MF, Apgar JR. IgE receptor-mediated
arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells:
possible role in activating degranulation. Mol Immunol. 1992
Nov;29(11):1299-308. PubMed PMID: 1328876.
121: Schiess K, Kaszkin M, Jordan P, Seidler L, Kinzel V. Mobilization
of diacylglycerol in intact HeLa cells by exogenous phospholipase C from
Cl. perfringens is accompanied by release of fatty acids including
arachidonic acid. Biochim Biophys Acta. 1992 Oct 6;1137(1):82-94. PubMed
PMID: 1327153.
122: Haeffner EW, Strosznajder JB. Metabolism of [14C]arachidonic
acid-labeled lipids in quiescent and OAG-stimulated ascites tumor cells.
Int J Biochem. 1992 Sep;24(9):1481-5. PubMed PMID: 1426529.
123: Larsson C, Saermark T, Mau S, Simonsson P. Activation of protein
kinase C in permeabilized human neuroblastoma SH-SY5Y cells. J Neurochem.
1992 Aug;59(2):644-51. PubMed PMID: 1378489.
124: Wu YN, Yang YC, Wagner PD. Modification of chromaffin cells with
pertussis toxin or N-ethylmaleimide lowers cytoskeletal F-actin and
enhances Ca(2+)-dependent secretion. J Biol Chem. 1992 Apr
25;267(12):8396-403. PubMed PMID: 1569091.
125: Mutch DG, Powell CB, Kao MS, Collins JL. Resistance to cytolysis by
tumor necrosis factor alpha in malignant gynecological cell lines is
associated with the expression of protein(s) that prevent the activation
of phospholipase A2 by tumor necrosis factor alpha. Cancer Res. 1992 Feb
15;52(4):866-72. PubMed PMID: 1737348.
126: Boschman GA, Manders EM, Rens W, Slater R, Aten JA. Semi-automated
detection of aberrant chromosomes in bivariate flow karyotypes.
Cytometry. 1992;13(5):469-77. PubMed PMID: 1633726.
127: Smith H, Crandall I, Prudhomme J, Sherman IW. Optimization and
inhibition of the adherent ability of Plasmodium falciparum-infected
erythrocytes. Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:303-12. PubMed
PMID: 1343707.
128: Gerrard JM, Israels ED, Bishop AJ, Schroeder ML, Beattie LL,
McNicol A, Israels SJ, Walz D, Greenberg AH, Ray M, et al. Inherited
platelet-storage pool deficiency associated with a high incidence of
acute myeloid leukaemia. Br J Haematol. 1991 Oct;79(2):246-55. PubMed
PMID: 1958483.
129: Imaida K, Yoshida J, Uneyama C, Ogasawara H, Imazawa T, Hayashi Y.
Dose-dependent enhancing effects of quinacrine on induction of
preneoplastic glutathione S-transferase placental form positive liver
cell foci in male F344 rats. Carcinogenesis. 1991 Oct;12(10):1911-5.
PubMed PMID: 1934272.
130: Agrenius V, Chmielewska J, Widström O, Blombäck M. Increased
coagulation activity of the pleura after tube drainage and quinacrine
instillation in malignant pleural effusion. Eur Respir J. 1991
Oct;4(9):1135-9. PubMed PMID: 1836767.
131: Researchers assess data on long-term safety of non-surgical
sterilization method. Network. 1991 Sep;12(2):26-7. PubMed PMID:
12284277.
132: Boesch D, Muller K, Pourtier-Manzanedo A, Loor F. Restoration of
daunomycin retention in multidrug-resistant P388 cells by submicromolar
concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin
derivative. Exp Cell Res. 1991 Sep;196(1):26-32. PubMed PMID: 1879470.
133: O'Donnell KA, Howlett AC. Muscarinic receptor binding is inhibited
by quinacrine. Neurosci Lett. 1991 Jun 10;127(1):46-8. PubMed PMID:
1652714.
134: Castillo Jimeno JM, González de Garibay AS, Sebastían Borruel JL,
Valdivia Uría JG. [Acquired hydrocele in the adult: sclerotherapy]. Arch
Esp Urol. 1991 Jun;44(5):627-34. Review. Spanish. PubMed PMID: 1759878.
135: Krug HF, Culig H. Directed shift of fatty acids from phospholipids
to triacylglycerols in HL-60 cells induced by nanomolar concentrations
of triethyl lead chloride: involvement of a pertussis toxin-sensitive
pathway. Mol Pharmacol. 1991 Apr;39(4):511-6. PubMed PMID: 1901939.
136: Thielmann HW, Popanda O, Edler L. The effects of inhibitors of
topoisomerase II and quinacrine on ultraviolet-light-induced DNA
incision in normal and xeroderma pigmentosum fibroblasts. J Cancer Res
Clin Oncol. 1991;117(1):19-26. PubMed PMID: 1847700.
137: Branellec D, Markovits J, Chouaib S. Potentiation of TNF-mediated
cell killing by VP-16: relationship to DNA single-strand break
formation. Int J Cancer. 1990 Dec 15;46(6):1048-53. PubMed PMID:
2249891.
138: Spriggs DR, Sherman ML, Imamura K, Mohri M, Rodriguez C, Robbins G,
Kufe DW. Phospholipase A2 activation and autoinduction of tumor necrosis
factor gene expression by tumor necrosis factor. Cancer Res. 1990 Nov
15;50(22):7101-7. PubMed PMID: 2121330.
139: Shiiki S, Fuchimoto S, Orita K. A comparison of the antitumor
effects of natural human tumor necrosis factors alpha and beta: the
roles of arachidonic acid metabolism and intracellular cAMP. Jpn J Clin
Oncol. 1990 Sep;20(3):252-8. PubMed PMID: 2174997.
140: Schmid I, Anasetti C, Petersen FB, Storb R. Marrow transplantation
for severe aplastic anemia associated with exposure to quinacrine. Blut.
1990 Aug-Sep;61(2-3):52-4. PubMed PMID: 2207341.
141: Thresher RJ, Griffith JD. Intercalators promote the binding of RecA
protein to double-stranded DNA. Proc Natl Acad Sci U S A. 1990
Jul;87(13):5056-60. PubMed PMID: 2195545; PubMed Central PMCID:
PMC54260.
142: Turk D, Singer Z, Jukić S, Krstulović B. New technique for
processing paraffin-embedded tissue for Y chromosome fluorescence
identification of trophoblastic disease. Anal Quant Cytol Histol. 1990
Apr;12(2):146-8. PubMed PMID: 2161664.
143: Mohri M, Spriggs DR, Kufe D. Effects of lipopolysaccharide on
phospholipase A2 activity and tumor necrosis factor expression in HL-60
cells. J Immunol. 1990 Apr 1;144(7):2678-82. PubMed PMID: 2156930.
144: Osada S, Horibe K, Oiwa K, Yoshida J, Iwamura H, Matsuoka H, Adachi
K, Morishima Y, Ohno R, Ueda R, et al. A case of infantile acute
monocytic leukemia caused by vertical transmission of the mother's
leukemic cells. Cancer. 1990 Mar 1;65(5):1146-9. PubMed PMID: 2406008.
145: Ralph RK, Wojcik S. Inhibitors of lipoxygenase have
antiproliferative effects on P815 murine mastocytoma cells. Cancer Lett.
1990 Mar;49(3):181-5. PubMed PMID: 2107964.
146: Gao G, Serrero G. Phospholipase A2 is a differentiation-dependent
enzymatic activity for adipogenic cell line and adipocyte precursors in
primary culture. J Biol Chem. 1990 Feb 15;265(5):2431-4. PubMed PMID:
2303407.
147: Sherman ML, Weber BL, Datta R, Kufe DW. Transcriptional and
posttranscriptional regulation of macrophage-specific colony stimulating
factor gene expression by tumor necrosis factor. Involvement of
arachidonic acid metabolites. J Clin Invest. 1990 Feb;85(2):442-7.
Erratum in: J Clin Invest 1990 Apr;85(4):following 1338. PubMed PMID:
2105339; PubMed Central PMCID: PMC296443.
148: O'Connor PM, Kohn KW. Comparative pharmacokinetics of DNA lesion
formation and removal following treatment of L1210 cells with nitrogen
mustards. Cancer Commun. 1990;2(12):387-94. PubMed PMID: 2265064.
149: Gàti I, Bergström M, Westerberg G, Csòka K, Muhr C, Carlsson J.
Effects of prostaglandin and leukotriene inhibitors on the growth of
human glioma spheroids. Eur J Cancer. 1990;26(7):802-7. PubMed PMID:
2145898.
150: Baguley BC, Turner PM, Ferguson LR. Protection by inhibitors of
multidrug resistance against mitochondrial mutagenesis in Saccharomyces
cerevisiae. Eur J Cancer. 1990 Jan;26(1):55-60. PubMed PMID: 2138480.
151: Finlay GJ, Wilson WR, Baguley BC. Chemoprotection by
9-aminoacridine derivatives against the cytotoxicity of topoisomerase
II-directed drugs. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1695-701.
PubMed PMID: 2561099.
152: Parrow VC, Aleström P, Gautvik KM. 5-azacytidine-induced
alterations in the GH12C1 cells: effects on cellular morphology,
chromosome structure, DNA and protein synthesis. J Cell Sci. 1989 Jul;93
( Pt 3):533-43. PubMed PMID: 2481682.
153: Shirazi Y, McMorris FA, Shin ML. Arachidonic acid mobilization and
phosphoinositide turnover by the terminal complement complex, C5b-9, in
rat oligodendrocyte x C6 glioma cell hybrids. J Immunol. 1989 Jun
15;142(12):4385-91. PubMed PMID: 2542410.
154: Suematsu T, Hidaka T, Sakanashi T, Sugiyama M, Ogura R. Effect of
UV-B irradiation on release of arachidonic acid from B-16 melanoma
cells. Prostaglandins Leukot Essent Fatty Acids. 1989 Mar;35(3):153-6.
PubMed PMID: 2710798.
155: Ballerini P, Franchi A, Fuschiotti P, Piccioni D, Bonmassar E. Two
antiemetic regimens do not impair chemical xenogenization induced in
vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide. Cancer
Chemother Pharmacol. 1989;24(6):359-62. PubMed PMID: 2791188.
156: Ashinoff R, Werth VP, Franks AG Jr. Resistant discoid lupus
erythematosus of palms and soles: successful treatment with azathioprine.
J Am Acad Dermatol. 1988 Nov;19(5 Pt 2):961-5. PubMed PMID: 3192780.
157: Schneider E, Darkin SJ, Lawson PA, Ching LM, Ralph RK, Baguley BC.
Cell line selectivity and DNA breakage properties of the antitumour
agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA
topoisomerase II. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1783-90.
PubMed PMID: 2850193.
158: Kanamaru H, Hashimura T, Yoshida O. Effects of retinoids and
inhibitors of arachidonic acid metabolism on tumor-promoter-induced soft
agar colony formation of mouse epidermal cells and rat urinary bladder
cells. Jpn J Cancer Res. 1988 Sep;79(9):1043-7. PubMed PMID: 3142835.
159: Beck WT, Cirtain MC, Glover CJ, Felsted RL, Safa AR. Effects of
indole alkaloids on multidrug resistance and labeling of P-glycoprotein
by a photoaffinity analog of vinblastine. Biochem Biophys Res Commun.
1988 Jun 30;153(3):959-66. PubMed PMID: 2898941.
160: Kolber MA, Henkart PA. Quantitation of secretion by rat basophilic
leukemia cells by measurements of quinacrine uptake. Biochim Biophys
Acta. 1988 Apr 22;939(3):459-66. PubMed PMID: 3355827.
161: Inaba M, Maruyama E. Reversal of resistance to vincristine in P388
leukemia by various polycyclic clinical drugs, with a special emphasis
on quinacrine. Cancer Res. 1988 Apr 15;48(8):2064-7. PubMed PMID:
3349478.
162: Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared
by compounds that modulate multidrug resistance in human leukemic cells.
Mol Pharmacol. 1988 Apr;33(4):454-62. PubMed PMID: 3162758.
163: Asfari M, Thiébaud CH. Transplantation studies of a putative
lymphosarcoma of Xenopus. Cancer Res. 1988 Feb 15;48(4):954-7. PubMed
PMID: 3338087.
164: McCormick DL. Anticarcinogenic activity of quinacrine in the rat
mammary gland. Carcinogenesis. 1988 Jan;9(1):175-8. PubMed PMID:
3335042.
165: Darzynkiewicz Z, Kapuscinski J. Condensation of DNA in situ in
metaphase chromosomes induced by intercalating ligands and its
relationship to chromosome banding. Cytometry. 1988 Jan;9(1):7-18.
PubMed PMID: 3044712.
166: Hartley JA, Lown JW, Mattes WB, Kohn KW. DNA sequence specificity
of antitumor agents. Oncogenes as possible targets for cancer therapy.
Acta Oncol. 1988;27(5):503-10. Review. PubMed PMID: 2849464.
167: Kohn KW, Hartley JA, Mattes WB. Mechanisms of DNA sequence
selective alkylation of guanine-N7 positions by nitrogen mustards.
Nucleic Acids Res. 1987 Dec 23;15(24):10531-49. PubMed PMID: 3697095;
PubMed Central PMCID: PMC339961.
168: Hirafuji M, Nave JF. Platelet-activating factor (PAF-acether)
formation in rat basophilic leukemia cells stimulated by ionophore
A23187. Agents Actions. 1987 Oct;22(1-2):159-64. PubMed PMID: 3120519.
169: Misawa S, Staal SP, Testa JR. Amplification of the c-myc oncogene
is associated with an abnormally banded region on chromosome 8 or double
minute chromosomes in two HL-60 human leukemia sublines. Cancer Genet
Cytogenet. 1987 Sep;28(1):127-35. PubMed PMID: 3475162.
170: DeGeorge JJ, Ousley AH, McCarthy KD, Morell P, Lapetina EG.
Glucocorticoids inhibit the liberation of arachidonate but not the rapid
production of phospholipase C-dependent metabolites in
acetylcholine-stimulated C62B glioma cells. J Biol Chem. 1987 Jul
25;262(21):9979-83. PubMed PMID: 3112143.
171: Gitelman I, Dexter DF, Roder JC. DNA amplification and metastasis
of the human melanoma cell line MeWo. Cancer Res. 1987 Jul
15;47(14):3851-5. PubMed PMID: 3594442.
172: Puccetti P, Fuschiotti P, Dominici P, Borri-Voltattorni C, Romani
L, Fioretti MC. DNA methylating activity in murine lymphoma cells
xenogenized by triazene derivatives. Int J Cancer. 1987 Jun
15;39(6):769-73. PubMed PMID: 2438236.
173: Ofenstein JP, Rillema JA. Possible involvement of the
phospholipases in the mitogenic actions of prolactin (PRL) on Nb2 node
lymphoma cells. Proc Soc Exp Biol Med. 1987 Jun;185(2):147-52. PubMed
PMID: 3106986.
174: Bennett A, Melhuish PB, Patel S, Randles H, Stamford IF. Cancer in
mice: effects of prednisolone or mepacrine alone and with cytotoxic
drugs. Br J Cancer. 1987 Apr;55(4):385-8. PubMed PMID: 3580263; PubMed
Central PMCID: PMC2001699.
175: Inaba M. [Studies on the mechanism of multidrug resistance]. Gan To
Kagaku Ryoho. 1987 Mar;14(3 Pt 2):807-14. Japanese. PubMed PMID:
3471182.
176: Agah R, Shau H, Mazumder A. Lysosome rich cells contain the lytic
activity of lymphokine-activated killer cell populations. Cancer Immunol
Immunother. 1987;24(3):247-52. PubMed PMID: 3594487.
177: Russell DH, Buckley AR, Montgomery DW, Larson NA, Gout PW, Beer CT,
Putnam CW, Zukoski CF, Kibler R. Prolactin-dependent mitogenesis in Nb 2
node lymphoma cells: effects of immunosuppressive cyclopeptides. J
Immunol. 1987 Jan 1;138(1):276-84. PubMed PMID: 3097147.
178: Jadus MR, Schmunk G, Djeu JY, Parkman R. Morphology and lytic
mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor
necrosis factor as a possible mediator. J Immunol. 1986 Nov
1;137(9):2774-83. PubMed PMID: 2428873.
179: Evans PM, Lanham DF. Effects of inhibitors of arachidonic acid
metabolism on intercellular adhesion of SV40-3T3 cells. Cell Biol Int
Rep. 1986 Sep;10(9):693-8. PubMed PMID: 3019579.
180: McKinney M, Richelson E. Blockade of N1E-115 murine neuroblastoma
muscarinic receptor function by agents that affect the metabolism of
arachidonic acid. Biochem Pharmacol. 1986 Jul 15;35(14):2389-97. PubMed
PMID: 3015148.
181: Yoshida MA, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GR Jr,
Huben R, Sandberg AA. Cytogenetic studies of tumor tissue from patients
with nonfamilial renal cell carcinoma. Cancer Res. 1986 Apr;46(4 Pt
2):2139-47. PubMed PMID: 3948185.
182: Yoshida MA, Ohyashiki K, Piver SM, Sandberg AA. Recurrent
endometrial adenocarcinoma with rearrangement of chromosomes 1 and 11.
Cancer Genet Cytogenet. 1986 Feb 1;20(1-2):159-62. PubMed PMID: 3943058.
183: Bellucci S, Levy-Toledano S, Maclouf J, Rendu F, Tobelem G, Caen
JP. Thrombocytopenia with thrombocytopathy possibly related to
abnormalities of intracellular Ca++ fluxes and followed by the
development of leukaemia. Scand J Haematol. 1986 Feb;36(2):142-6. PubMed
PMID: 3085207.
184: Vanni R, Scarpa RM, Nieddu M, Usai E. Identification of marker
chromosomes in bladder tumor. Urol Int. 1986;41(6):403-6. PubMed PMID:
3824694.
185: Koike K, Judd AM, Login IS, Yasumoto T, MacLeod RM. Maitotoxin, a
calcium channel activator, increases prolactin release from rat
pituitary tumor 7315a cells by a mechanism that may involve leukotriene
production. Neuroendocrinology. 1986;43(3):283-90. PubMed PMID: 2426623.
186: Pfab R, Schachtschabel DO, Kern HF. [Ultrastructural studies of the
effect of x-rays and quinacrine (Atebrin) or chloroquine (Resochin)--alone
or in combination--on Harding-Passey melanoma cells in monolayer
culture]. Strahlentherapie. 1985 Nov;161(11):711-8. German. PubMed PMID:
4071571.
187: Giglia JS, Ovak GM, Yoshida MA, Twist CJ, Jeffery AR, Pauly JL.
Isolation of mouse T-cell lymphoma lines from different long-term
interleukin 2-dependent cultures. Cancer Res. 1985 Oct;45(10):5027-34.
PubMed PMID: 3875403.
188: Kreuser ED. [Malignant pleural effusions. Pathophysiology,
diagnosis and therapy]. Dtsch Med Wochenschr. 1985 Sep 6;110(36):1381-6.
Review. German. PubMed PMID: 2411492.
189: Lauzon RJ, Roder JC. Segregation of the NK-sensitive phenotype in
human x mouse somatic cell hybrids reveals separate genetic control of
recognition and postrecognition determinants. Cell Immunol. 1985
Aug;94(1):85-99. PubMed PMID: 2990738.
190: Terpstra P, Rommerts FF, van der Molen HJ. Are polyphosphorylated
phospholipids involved in the hormonal control of cholesterol side-chain
cleavage activity in tumour Leydig cells? J Steroid Biochem. 1985
Jun;22(6):773-80. PubMed PMID: 2991659.
191: Maroy B, Moullot P, Brulé M, Lancret C, Faure JY. [Collagenous
colitis coexisting with polyadenoma. Favorable effect of mepacrine].
Gastroenterol Clin Biol. 1985 May;9(5):453-4. French. PubMed PMID:
4007394.
192: Hausheer FH, Yarbro JW. Diagnosis and treatment of malignant
pleural effusion. Semin Oncol. 1985 Mar;12(1):54-75. Review. PubMed
PMID: 2579439.
193: Grunicke H, Doppler W, Hofmann J, Lindner H, Maly K, Oberhuber H,
Ringsdorf H, Roberts JJ. Plasma membrane as target of alkylating agents.
Adv Enzyme Regul. 1985;24:247-61. PubMed PMID: 2940819.
194: Holden JJ, Reimer DL, Higgins MJ, Roder JC, White BN. Amplified
sequences from chromosome 15, including centromeres, nucleolar organizer
regions, and centromeric heterochromatin, in homogeneously staining
regions in the human melanoma cell line MeWo. Cancer Genet Cytogenet.
1985 Jan 1;14(1-2):131-46. PubMed PMID: 2578090.
195: Snider RM, Richelson E. Bradykinin receptor-mediated cyclic GMP
formation in a nerve cell population (murine neuroblastoma clone
N1E-115). J Neurochem. 1984 Dec;43(6):1749-54. PubMed PMID: 6149270.
196: Ferrante A, Goh DH. The effect of anti-malarial drugs on human
natural killer cells in vitro. Parasite Immunol. 1984 Nov;6(6):571-80.
PubMed PMID: 6335236.
197: Snider RM, McKinney M, Fenton JW 2nd, Richelson E. Activation of
cyclic nucleotide formation in murine neuroblastoma N1E-115 cells by
modified human thrombins. J Biol Chem. 1984 Jul 25;259(14):9078-81.
PubMed PMID: 6086621.
198: Darzynkiewicz Z, Traganos F, Kapuscinski J, Staiano-Coico L,
Melamed MR. Accessibility of DNA in situ to various fluorochromes:
relationship to chromatin changes during erythroid differentiation of
Friend leukemia cells. Cytometry. 1984 Jul;5(4):355-63. PubMed PMID:
6468176.
199: Snider RM, McKinney M, Forray C, Richelson E. Neurotransmitter
receptors mediate cyclic GMP formation by involvement of arachidonic
acid and lipoxygenase. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3905-9.
PubMed PMID: 6328532; PubMed Central PMCID: PMC345331.
200: Morton CC, Kirsch IR, Taub R, Orkin SH, Brown JA. Localization of
the beta-globin gene by chromosomal in situ hybridization. Am J Hum
Genet. 1984 May;36(3):576-85. PubMed PMID: 6587773; PubMed Central
PMCID: PMC1684456.
201: Simmons MC, Maxwell J, Haliotis T, Higgins MJ, Roder JC, White BN,
Holden JJ. Amplified KpnL repetitive DNA sequences in homogeneously
staining regions of a human melanoma cell line. J Natl Cancer Inst. 1984
Apr;72(4):801-8. PubMed PMID: 6200639.
202: Davis JR, Surwit EA, Garay JP, Fortier KJ. Sex assignment in
gestational trophoblastic neoplasia. Am J Obstet Gynecol. 1984 Mar
15;148(6):722-5. PubMed PMID: 6322588.
203: Oikawa T, Kuzumaki N, Yamada T. Specific chromosome translocation
in pristane-induced plasmacytomas of NZB mice. J Natl Cancer Inst. 1984
Feb;72(2):347-53. PubMed PMID: 6582321.
204: Louache F, Villeval JL, Pelicci PG, Rouis M, Titeux M, Henri A,
Rochant H, Thomopoulos P, Testa U. Characterization of phorbol esters
binding to K 562 cells. Anticancer Res. 1984 Jan-Apr;4(1-2):33-9. PubMed
PMID: 6324650.
205: Hasegawa-Sasaki H, Sasaki T. Phytohemagglutinin induces rapid
degradation of phosphatidylinositol 4,5-bisphosphate and transient
accumulation of phosphatidic acid and diacylglycerol in a human T
lymphoblastoid cell line, CCRF-CEM. Biochim Biophys Acta. 1983 Dec
20;754(3):305-14. PubMed PMID: 6317043.
206: Fioretti MC, Bianchi R, Romani L, Bonmassar E. Drug-induced
immunogenic changes of murine leukemia cells: dissociation of onset of
resistance and emergence of novel immunogenicity. J Natl Cancer Inst.
1983 Dec;71(6):1247-51. PubMed PMID: 6581361.
207: Halpern J, Hinkle PM. Binding and internalization of epidermal
growth factor by rat pituitary tumor cells. Mol Cell Endocrinol. 1983
Dec;33(2-3):183-96. PubMed PMID: 6317483.
208: Moriuchi T, Oikawa T, Kodama T, Yamaguchi H, Kobayashi H.
Establishment and characterization of a transplantable rat
myelomonocytic leukemia. Cancer Res. 1983 Nov;43(11):5478-83. PubMed
PMID: 6577949.
209: Da Cunha MF, Meistrich ML, Ried HL, Gordon LA, Watchmaker G,
Wyrobek AJ. Active sperm production after cancer chemotherapy with
doxorubicin. J Urol. 1983 Nov;130(5):927-30. PubMed PMID: 6415299.
210: Heikkilä R, Iversen JG, Godal T. Early, anti-immunoglobulin induced
events prior to Na+-K+ pump activation: an analysis in a monoclonal
human B-lymphoma cell population. J Cell Physiol. 1983 Oct;117(1):1-8.
PubMed PMID: 6311844.
211: Pfab R, Schachtschabel DO, Paul N, Biller H, Hess F. [Ultrastructural
studies on the effect of roentgen rays and quinacrine (atebrin)--alone
or in combination--on Ehrlich ascites tumor cells in monolayer culture].
Strahlentherapie. 1983 Aug;159(8):495-501. German. PubMed PMID: 6684812.
212: Testa U, Pelicci PG, Thomopoulos P, Titeux M, Rochant H. The number
of the Trf receptors on human hematopoietic cell lines is influenced by
membrane phospholipids. Biochem Int. 1983 Aug;7(2):169-78. PubMed PMID:
6089809.
213: Mockus MB, Horwitz KB. Progesterone receptors in human breast
cancer. Stoichiometric translocation and nuclear receptor processing. J
Biol Chem. 1983 Apr 25;258(8):4778-83. PubMed PMID: 6833276.
214: Sytkowski AJ, Richie JP, Bicknell KA. New human renal carcinoma
cell line established from a patient with erythrocytosis. Cancer Res.
1983 Mar;43(3):1415-9. PubMed PMID: 6825111.
215: Richman CM, Rowley JD. Correlation of in vitro culture pattern and
Q-banded karyotype in acute nonlymphocytic leukemia. Am J Hematol. 1983
Feb;14(1):37-47. PubMed PMID: 6837567.
216: Pawlak JW, Pawlak K, Konopa J. The mode of action of cytotoxic and
antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding
of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and
other macromolecules of mammalian or bacterial cells. Chem Biol
Interact. 1983 Feb;43(2):151-73. PubMed PMID: 6402314.
217: Shitara N, McKeever PE, Cummins C, Smith BH, Kornblith PL, Hirata
F. beta-Adrenergic receptor desensitization stimulates glucose uptake in
C6 rat glioma cells. Biochem Biophys Res Commun. 1982 Dec
15;109(3):753-61. PubMed PMID: 6297489.
218: Rogers AM, Back KC. Comparative mutagenicity of 4 DNA-intercalating
agents in L5178Y mouse lymphoma cells. Mutat Res. 1982
Dec;102(4):447-55. PubMed PMID: 7177152.
219: Reichmann A, Martin P, Levin B. Karyotypic findings in a colonic
villous adenoma. Cancer Genet Cytogenet. 1982 Sep;7(1):51-7. PubMed
PMID: 7139593.
220: Murato K, Monard D. Inhibition of S-adenosylmethionine-linked
methylation can lead to neurite extension in neuroblastoma cells. FEBS
Lett. 1982 Aug 2;144(2):321-5. PubMed PMID: 6811326.
221: Biller H, Schachtschabel DO, Leising HB, Pfab R, Hess F. [Influence
of x-rays and quinacrine (atebrine) or chloroquine (resochine)--alone or
in combination--on growth and melanin formation of Harding-Passey
melanoma cells in monolayer culture]. Strahlentherapie. 1982
Jul;158(7):450-6. German. PubMed PMID: 7135443.
222: Lerman SJ, Walker RA. Treatment of giardiasis: literature review
and recommendations. Clin Pediatr (Phila). 1982 Jul;21(7):409-14.
Review. PubMed PMID: 7044642.
223: Nakadate T, Yamamoto S, Ishii M, Kato R. Inhibition of
12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine
decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase
inhibitor. Cancer Res. 1982 Jul;42(7):2841-5. PubMed PMID: 6805948.
224: Tanaka M, Hibasami H, Nagai J, Ikeda T. Effect of DNA-binding drugs
on the activity of DNA methylase from Ehrlich's ascites tumour cells.
Aust J Exp Biol Med Sci. 1982 Jun;60(3):223-9. PubMed PMID: 7138412.
225: Morten J, Harnden DG, Bundey S. Family studies on the chromosomal
location of the retinoblastoma gene (Rb-1). J Med Genet. 1982
Apr;19(2):120-4. PubMed PMID: 6951997; PubMed Central PMCID: PMC1048841.
226: Schwarz G, Wittekind D. Selected aminoacridines as fluorescent
probes in cytochemistry in general and in the detection of cancer cells
in particular. Anal Quant Cytol. 1982 Mar;4(1):44-54. PubMed PMID:
6176157.
227: Johnson FB. Chemical interactions with herpes simplex type 2 virus:
enhancement of transformation by selected chemical carcinogens and
pro-carcinogens. Carcinogenesis. 1982;3(10):1235-40. PubMed PMID:
6293737.
228: McGivney A, Morita Y, Crews FT, Hirata F, Axelrod J, Siraganian RP.
Phospholipase activation in the IgE-mediated and Ca2+ ionophore
A23187-induced release of histamine from rat basophilic leukemia cells.
Arch Biochem Biophys. 1981 Dec;212(2):572-80. PubMed PMID: 6173019.
229: Fishman PH, Mallorga P, Tallman JF. Catecholamine-induced
desensitization of adenylate cyclase in rat glioma C6 cells. Evidence
for a specific uncoupling of beta-adrenergic receptors from a functional
regulatory component of adenylate cyclase. Mol Pharmacol. 1981
Sep;20(2):310-8. PubMed PMID: 6272090.
230: Petersen SE, Frederiksen P, Friedrich U. Cytogenetic analysis and
flow cytometric DNA measurement of a human tumor with pronounced
hypodiploidy. Cancer Genet Cytogenet. 1981 Aug;4(1):1-9. PubMed PMID:
7284987.
231: Yamamoto S, Kawasaki T. The involvement of the membrane
oxidoreduction system in stimulating amino acid uptake in Ehrlich
ascites tumor cells. Biochim Biophys Acta. 1981 Jun 22;644(2):192-200.
PubMed PMID: 7260073.
232: Bauer F. Quinacrine hydrochloride drug eruption (tropical lichenoid
dermatitis). Its early and late sequelae and its malignant potential: a
review. J Am Acad Dermatol. 1981 Feb;4(2):239-48. PubMed PMID: 6452466.
233: Hecht F, Kaiser-McCaw B. Position effect in 8;14 translocation in
Burkitt's lymphoma. N Engl J Med. 1981 Jan 15;304(3):174-5. PubMed PMID:
7442741.
234: Biller H, Schachtschabel DO, Leising HB, Pfab R, Hess F.
[Intensification of the inhibitory effect of X-rays on the growth of
Ehrlich ascites tumor cells in monolayer culture by quinacrine (atebrine)
or chloroquine (resochine) (author's transl)]. Strahlentherapie. 1980
Aug;156(8):547-53. German. PubMed PMID: 7414650.
235: Shade M, Woodward MA, Steel CM. Chromosome aberrations acquired in
vitro by human B-cell lines. II. Distribution of break points. J Natl
Cancer Inst. 1980 Jul;65(1):101-9. PubMed PMID: 6967123.
236: Verma RS, Dosik H. Heteromorphisms of the Philadelphia (Ph1)
chromosome in patients with chronic melogenous leukaemia (CML). I.
Classification and clinical significance. Br J Haematol. 1980
Jun;45(2):215-22. PubMed PMID: 6934005.
237: McLoud TC, Isler R, Head J. The radiologic appearance of chemical
pleurodesis. Radiology. 1980 May;135(2):313-7. PubMed PMID: 7367618.
238: Mallorga P, Tallman JF, Henneberry RC, Hirata F, Strittmatter WT,
Axelrod J. Mepacrine blocks beta-adrenergic agonist-induced
desensitization in astrocytoma cells. Proc Natl Acad Sci U S A. 1980
Mar;77(3):1341-5. PubMed PMID: 6246490; PubMed Central PMCID: PMC348490.
239: Giampietri A, Fioretti MC, Goldin A, Bonmassar E. Drug-mediated
antigenic changes in murine leukemia cells: antagonistic effects of
quinacrine, an antimutagenic compound. J Natl Cancer Inst. 1980
Feb;64(2):297-301. PubMed PMID: 6928222.
240: Zeitz M, Lange K, Noske W, Keller K, Herken H. Further studies on
the nature of red fluorescent structures in neuroblastoma monolayer
cells vitally stained with acridine orange. Naunyn Schmiedebergs Arch
Pharmacol. 1980 Feb;311(1):53-9. PubMed PMID: 6154246.
241: Kivi S, Mikelsaar AV. Q- and C-band polymorphisms in patients with
ovarian or breast carcinoma. Hum Genet. 1980;56(1):111-4. PubMed PMID:
7203477.
242: Tadano J, Niwa M, Nagumo F, Watanabe K, Arimori S. A case of acute
myeloblastic leukemia with chromosomes showing 46, XY = 11/46, XY, 21q-
= 39. Tokai J Exp Clin Med. 1980 Jan;5(1):45-50. PubMed PMID: 6930118.
243: Callaway JL. Late sequelae of quinacrine dermatitis, a new
premalignant entity. J Am Acad Dermatol. 1979 Nov;1(5):456. PubMed PMID:
512094.
244: Stiksa G, Korsgaard R, Simonsson BG. Treatment of recurrent pleural
effusion by pleurodesis with quinacrine. Comparison between instillation
by repeated thoracenteses and by tube drainage. Scand J Respir Dis. 1979
Aug;60(4):197-205. PubMed PMID: 531540.
245: Austin EH, Flye MW. The treatment of recurrent malignant pleural
effusion. Ann Thorac Surg. 1979 Aug;28(2):190-203. Review. PubMed PMID:
383031.
246: Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW.
Establishment and characterization of a human prostatic carcinoma cell
line (PC-3). Invest Urol. 1979 Jul;17(1):16-23. PubMed PMID: 447482.
247: Garson OM. Chromosome-banding techniques and their implication in
hematology. Prog Hematol. 1979;11:83-114. Review. PubMed PMID: 392596.
248: Cimino MC, Rowley JD, Kinnealey A, Variakojis D, Golomb HM. Banding
studies of chromosomal abnormalities in patients with acute lymphocytic
leukemia. Cancer Res. 1979 Jan;39(1):227-38. PubMed PMID: 367578.
249: D'Alisa RM, Korf BR, Gershey EL. T antigen banding on chromosomes
of simian virus 40 infected muntjac cells. Cytogenet Cell Genet.
1979;24(1):27-36. PubMed PMID: 88306.
250: Nouvel C, Caranobe C, Sie P, Capdeville J, Pris J, Boneu B.
Platelet volume, density and 5 HT organelles (mepacrine test) in acute
leukaemia. Scand J Haematol. 1978 Nov;21(5):421-6. PubMed PMID: 282662.
251: Golomb HM, Vardiman JW, Rowley JD, Testa JR, Mintz U. Correlation
of clinical findings with quinacrine-banded chromosomes in 90 adults
with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N
Engl J Med. 1978 Sep 21;299(12):613-9. PubMed PMID: 79982.
252: Viallet P, Kohen E, Schachtschabel DO, Marty A, Salmon JM, Kohen C,
Leising HB, Thorell B. The effect of atebrine and an acridine analog
(BCMA) on the coenzyme fluorescence spectra of cultured melanoma and
Ehrlich ascites (EL2) cells. Histochemistry. 1978 Sep 15;57(3):189-201.
PubMed PMID: 30739.
253: Bocian M, Mohandas T. Recent cytogenetic advances and implications
for pediatric practice. Pediatr Clin North Am. 1978 Aug;25(3):517-38.
PubMed PMID: 567777.
254: Bauer F. Late sequelae of atabrine dermatitis--a new pre-malignant
entity. Australas J Dermatol. 1978 Apr;19(1):9-12. PubMed PMID: 150840.
255: Leff A, Hopewell PC, Costello J. Pleural effusion from malignancy.
Ann Intern Med. 1978 Apr;88(4):532-7. Review. PubMed PMID: 76455.
256: Bayly TC, Kisner DL, Sybert A, Macdonald JS, Tsou E, Schein PS.
Tetracycline and quinacrine in the control of malignant pleural
effusions. A randomized trial. Cancer. 1978 Mar;41(3):1188-92. PubMed
PMID: 346189.
257: Sugiyama T, Uenaka H, Ueda N, Fukuhara S, Maeda S. Reproducible
chromosome changes of polycyclic hydrocarbon-induced rat leukemia:
incidence and chromosome banding pattern. J Natl Cancer Inst. 1978
Jan;60(1):153-60. PubMed PMID: 415146.
258: Bychkov MB. [Delagil treatment of tumorous pleurisy]. Vopr Onkol.
1978;24(2):85-8. Russian. PubMed PMID: 345624.
259: Greenwald DW, Phillips C, Bennett JM. Management of malignant
pleural effusion. J Surg Oncol. 1978;10(4):361-8. PubMed PMID: 80514.
260: Mejer J, Mortensen KM, Hansen HH. Mepacrine hydrochloride in the
treatment of malignant pleural effusion. A controlled randomized trial.
Scand J Respir Dis. 1977 Dec;58(6):319-23. PubMed PMID: 415356.
261: Rapp M, Therman E. The effect of procarbazine on the chromosomes of
normal and malignant mouse cells. Ann Genet. 1977 Dec;20(4):249-54.
PubMed PMID: 305751.
262: Herz F, Miller OJ, Miller DA, Auersperg N, Koss LG. Chromosome
analysis and alkaline phosphatase of C41, a cell line of human cervical
origin distinct from HeLa. Cancer Res. 1977 Sep;37(9):3209-13. PubMed
PMID: 560251.
263: Nagao K, Yonemitsu H, Yamaguchi K, Okuda K. A case of acute
myeloblastic leukemia with Ph1 chromosome showing translocation
9q+;22q-. Blood. 1977 Aug;50(2):259-62. PubMed PMID: 266953.
264: Cantatore D, Pezza A. [Diagnosis and therapy of neoplastic
pleurisy. Clinical progress]. Arch Monaldi. 1977 Jul-Aug;32(4):280-92.
Italian. PubMed PMID: 84660.
265: Alt B. Chromosome studies of the transplantable Shay chloroleukemia
in rats. J Natl Cancer Inst. 1977 May;58(5):1437-42. PubMed PMID:
266085.
266: Garcia-Sancho J, Sanchez A, Handlogten ME, Christensen HN.
Unexpected additional mode of energization of amino-acid transport into
Ehrlich cells. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1488-91. PubMed
PMID: 266189; PubMed Central PMCID: PMC430811.
267: Taylor SA, Hooton NS, Macarthur AM. Quinacrine in the management of
malignant pleural effusion. Br J Surg. 1977 Jan;64(1):52-3. PubMed PMID:
831956.
268: Takahashi M. A behavior of Y chromatin in cancer cells of males.
Acta Cytol. 1977 Jan-Feb;21(1):132-6. PubMed PMID: 189543.
269: Whang-Peng J. Banding in leukemia: techniques and implications. J
Natl Cancer Inst. 1977 Jan;58(1):3-8. PubMed PMID: 64613.
270: Christensen HN. Amino acid transport systems in animal cells:
interrelations and energization. J Supramol Struct. 1977;6(2):205-13.
PubMed PMID: 20537.
271: Rowley JD. Editorial: The role of cytogenetics in hematology.
Blood. 1976 Jul;48(1):1-7. PubMed PMID: 1065388.
272: Golomb HM, Vardiman J, Rowley JD. Acute nonlymphocytic leukemia in
adults: correlations with Q-banded chromosomes. Blood. 1976
Jul;48(1):9-21. PubMed PMID: 59614.
273: Rowley JD, Potter D. Chromosomal banding patterns in acute
nonlymphocytic leukemia. Blood. 1976 May;47(5):705-21. PubMed PMID:
1260131.
274: Francke U. Retinoblastoma and chromosome 13. Birth Defects Orig
Artic Ser. 1976;12(7):131-4. PubMed PMID: 1024606.
275: McCaw B, Hecht F, Linder D, Lovrien EW, Wyandt H, Bacon D, Clark B,
Lea N. Ovarian teratomas: cytologic data. Birth Defects Orig Artic Ser.
1976;12(7):391-5. PubMed PMID: 66945.
276: Zech L, Jindsten J, Udén AM, Gahrton G. Monosomy 7 in two adult
patients with acute myeloblastic leukaemia. Scand J Haematol. 1975
Nov;15(4):251-5. PubMed PMID: 1060173.
277: Mattock NM, Peters W. The experimental chemotherapy of
leishmaniasis. II. The activity in tissue culture of some antiparasitic
and antimicrobial compounds in clinical use. Ann Trop Med Parasitol.
1975 Sep;69(3):359-71. PubMed PMID: 1155997.
278: Morin LJ, Loening S. Malignant androblastoma (Sertoli cell tumor)
of the testis. A case report with a review of the literature. J Urol.
1975 Sep;114(3):476-80. PubMed PMID: 167202.
279: Johnson LP, Rivkin SE, Weber EL. Palliation in malignant pleural
effusion. Am Surg. 1975 Sep;41(9):529-34. PubMed PMID: 52306.
280: Misawa S, Takino T, Sugishima K, Abe T. Quinacrine-banding analysis
of the Philadelphia chromosome from five patients with chronic
myelogeneous leukemia. Nippon Ketsueki Gakkai Zasshi. 1975
Jun;38(3):307-10. PubMed PMID: 1061477.
281: Hayek A, Yunis E. Dicentric Y chromosome in mixed gonadal
dysgenesis. J Med Genet. 1975 Jun;12(2):210-2. PubMed PMID: 49429;
PubMed Central PMCID: PMC1013268.
282: DiPaolo JA. Karyological instability of neoplastic somatic cells.
In Vitro. 1975 Mar-Apr;11(2):89-96. PubMed PMID: 50282.
283: Gutierrez AC, Salamanca F, Lisker R, Segovia A. Supernumerary
bisatellited chromosome in a family ascertained through a patient with
Sturge-Weber syndrome. Ann Genet. 1975 Mar;18(1):45-9. PubMed PMID:
50042.
284: Hellriegel KP, Borberg H, Reitz H, Gross R. Evaluation of the
efficiency of leukocyte transfers by Y-chromatin studies. Transplant
Proc. 1974 Dec;6(4):399-403. PubMed PMID: 4140593.
285: Hossfeld DK. Identification of chromosome anomalies in the blastic
phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding
techniques. Humangenetik. 1974 Jul 15;23(2):111-8. PubMed PMID: 4136793.
286: Gahrton G, Lindsten J, Zech L. Clonal origin of the Philadelphia
chromosome from either the paternal or the maternal chromosome number
22. Blood. 1974 Jun;43(6):837-40. PubMed PMID: 4133980.
287: Borgaonkar DS, Bias WB, Sroka BM, Hutchinson JR, Santos GW.
Identification of graft and host cells in bone marrow transplants by the
quinacrine banding technique of chromosome identification. Acta Cytol.
1974 May-Jun;18(3):263-7. PubMed PMID: 4134795.
288: Inoue S, Ravindranath Y, Ottenbreit MJ, Thompson RI, Zuelzer WW.
Chromosomal analysis of metastatic retinoblastoma cells. Humangenetik.
1974;25(2):111-8. PubMed PMID: 4442883.
289: Smith FE, Lane M, Hudgins PT. Conservative management of malignant
pericardial effusion. Cancer. 1974 Jan;33(1):47-57. PubMed PMID:
4272474.
290: Raposa T, Natarajan AT. Fluorescence banding pattern of human and
mouse chromosomes with a benzimidazol derivative (Hoechst 33258).
Humangenetik. 1974;21(3):221-6. PubMed PMID: 4136266.
291: Mitelman F. Heterogeneity of Ph1 in chronic myeloid leukaemia.
Hereditas. 1974;76(2):315-6. PubMed PMID: 4135826.
292: Berger R. [Letter: Philadelphia chromosome]. Nouv Presse Med. 1973
Dec;2(46):3121. French. PubMed PMID: 4522825.
293: Shaw MW. Uses of banding techniques for the identification of human
diseases of cytogenetic origin. Environ Health Perspect. 1973
Dec;6:151-6. PubMed PMID: 4131094; PubMed Central PMCID: PMC1475549.
294: Marshall R. Q-band chromosome patterns of a variant of the BHK-21
C13 cell line. J Natl Cancer Inst. 1973 Nov;51(5):1697-700. PubMed PMID:
4128487.
295: Oshimura M, Sasaki M, Makino S. Chromosomal banding patterns in
primary and transplanted venereal tumors of the dog. J Natl Cancer Inst.
1973 Oct;51(4):1197-203. PubMed PMID: 4126856.
296: Khudr G, Walsh PC, Benirschke K. Quinacrine fluorescence of
testicular tumors. Urology. 1973 Aug;2(2):162-4. PubMed PMID: 4769519.
297: Rowley JD. Letter: A new consistent chromosomal abnormality in
chronic myelogenous leukaemia identified by quinacrine fluorescence and
Giemsa staining. Nature. 1973 Jun 1;243(5405):290-3. PubMed PMID:
4126434.
298: Rowley JD. Identificaton of a translocation with quinacrine
fluorescence in a patient with acute leukemia. Ann Genet. 1973
Jun;16(2):109-12. PubMed PMID: 4125056.
299: Allderdice PW, Miller OJ, Pearson PL, Klein G, Harris H. Human
chromosomes in 18 man-mouse somatic hybrid cell lines analysed by
quinacrine fluorescence. J Cell Sci. 1973 May;12(3):809-30. PubMed PMID:
4124328.
300: Borja ER, Pugh RP. Single-dose quinacrine (atabrine) and
thoracostomy in the control of pleural effusions in patients with
neoplastic diseases. Cancer. 1973 Apr;31(4):899-902. PubMed PMID:
4706055.
301: Gahrton G, Lindsten J, Zech L. Origin of the Philadelphia
chromosome. Tracing of chromosome 22 to parents of patients with chronic
myelocytic leukemia. Exp Cell Res. 1973 Apr;79(1):246-7. PubMed PMID:
4521679.
302: Gahrton G, Lindsten J, Zech L. Origin of the Philadelphia
chromosome. Tracing of chromosome 22 to parents of patients with chronic
myelocytic leukemia. Exp Eye Res. 1973 Apr;79(1):246-7. PubMed PMID:
4513631.
303: Peterson WD Jr, Simpson WF, Ecklund PS, Stulberg CS. Diploid and
heteroploid human cell lines surveyed for Y chromosome fluorescence. Nat
New Biol. 1973 Mar 7;242(114):22-4. PubMed PMID: 4120834.
304: Baserga A, Castoldi GL. The Philadelphia chromosome. Biomedicine.
1973 Mar;18(2):89-94. Review. PubMed PMID: 4125985.
305: Hinkes E, Crandall BF, Weber F, Craddock CG. Acute leukemia with
C-G chromosome translocation. Blood. 1973 Feb;41(2):259-63. PubMed PMID:
4513456.
306: Atkin NB. Y bodies and similar fluorescent chromocentres in human
tumours including teratomata. Br J Cancer. 1973 Feb;27(2):183-9. PubMed
PMID: 4121034; PubMed Central PMCID: PMC2008842.
307: Granberg I, Gupta S, Zech L. Chromosome analyses of a metastatic
gastric carcinoma including quinacrine fluorescence. Hereditas.
1973;75(2):189-94. PubMed PMID: 4782040.
308: Arvastson B, Boe J, Stiksa J, Simonsson BG. Mepacrine in malignant
pleural effusion. Scand J Respir Dis. 1973;54(2):132-5. PubMed PMID:
4707479.
309: Miller OJ, Miller DA, Warburton D. Application of new staining
techniques to the study of human chromosomes. Prog Med Genet.
1973;9:1-47. Review. PubMed PMID: 4123248.
310: Miller DA, Dev VG, Borek C, Miller OJ. The quinacrine fluorescent
and Giemsa banding karyotype of the rat, Rattus norvegicus, and banded
chromosome analysis of transformed and malignant rat liver cell lines.
Cancer Res. 1972 Nov;32(11):2375-82. PubMed PMID: 4343230.
311: Sellyei M, Vass L. Absence of fluorescent Y bodies in some
malignant epithelial tumours in human males: preliminary results. Eur J
Cancer. 1972 Oct;8(5):557-9. PubMed PMID: 4651787.
312: Pierre RV, Hoagland HC. Age-associated aneuploidy: loss of Y
chromosome from human bone marrow cells with aging. Cancer. 1972
Oct;30(4):889-94. PubMed PMID: 4116908.
313: Hiller E, Rosenow EC 3rd, Olsen AM. Pulmonary manifestations of the
yellow nail syndrome. Chest. 1972 May;61(5):452-8. PubMed PMID: 5046843.
314: Kegel J, Conen PE. Nuclear sex identification in human tissues: a
histologic study using quinacrine fluorescence. Am J Clin Pathol. 1972
Apr;57(4):425-30. PubMed PMID: 4111075.
315: Wolman SR, Phillips TF, Becker FF. Fluorescent banding patterns of
rat chromosomes in normal cells and primary hepatocellular carcinomas.
Science. 1972 Mar 17;175(27):1267-9. PubMed PMID: 4110697.
316: Castoldi GL, Grusovin GD, Scapoli GL, Spanedda R. [Study of
chromocenters in Reed-Sternberg cells]. Haematologica.
1972;57(9):505-14. Italian. PubMed PMID: 4125446.
317: Petit P, Verhest A, Lecluse van der Bilt F, Jongsma A. The
chromosomes of the EB virus-positive Burkitt cell line P3J.HR1K studied
by the fluorescent staining technique. Pathol Eur. 1972;7(1):17-21.
PubMed PMID: 4115493.
318: Lamborot-Manzur M, Tishler PV, Atkins L. Quantitative studies of Y
chromosomal fluorescence in human interphase nuclei. Clin Genet.
1972;3(2):103-15. PubMed PMID: 4115478.
319: Garson OM, Milligan WJ. The 45, XO, Ph 1 subgroup of chronic
granulocytic leukaemia. Scand J Haematol. 1972;9(2):186-92. PubMed PMID:
4114015.
320: Zech L. The identification of human chromosomes by fluorescence
technics. Biochem J. 1971 Oct;124(5):38P-39P. PubMed PMID: 5167133;
PubMed Central PMCID: PMC1177291.
321: Lee M, Boyes DA. The use of quinacrine hydrochloride for the
control of malignant serous effusions. J Obstet Gynaecol Br Commonw.
1971 Sep;78(9):843-4. PubMed PMID: 5097172.
322: Farber LR. Correctable complications of neoplastic disease. 3.
Neoplastic effusions. Conn Med. 1971 Jun;35(6):411-2. PubMed PMID:
5165442.
323: Chromosome identification. Can Med Assoc J. 1971 May 22;104(10):938
passim. PubMed PMID: 5574064; PubMed Central PMCID: PMC1930746.
324: O'Riordan ML, Robinson JA, Buckton KE, Evans HJ. Distinguishing
between the chromosomes involved in Down's syndrome (trisomy 21) and
cronic myeloid leukaemia (Ph1) by fluorescence. Nature. 1971 Mar
19;230(5290):167-8. PubMed PMID: 4100531.
325: Still more light on human chromosomes. Nature. 1971 Mar
19;230(5290):145. PubMed PMID: 4100530.
326: Farrow MG, Van Dyke K. A micro-system for screening anti-leukemic
drugs utilizing human whole blood. Chemotherapy. 1971;16(2):76-84.
PubMed PMID: 5120611.
327: Manolov G, Manolova Y, Levan A, Klein G. Experiments with
fluorescent chromosome staining in Burkitt tumors. Hereditas.
1971;68(2):235-44. PubMed PMID: 4142009.
328: Caspersson T, Gahrton G, Lindsten J, Zech L. Identification of the
Philadelphia chromosome as a number 22 by quinacrine mustard
fluorescence analysis. Exp Cell Res. 1970 Nov;63(1):238-40. PubMed PMID:
5276176.
329: Atkin NB. Y chromosomes and quinacrine fluorescence technique. Br
Med J. 1970 Oct 10;4(5727):118. PubMed PMID: 4098287; PubMed Central
PMCID: PMC1819622.
330: Berns MW, el-Kadi S, Olson RS, Rounds DE. Laser photosensitization
and metabolic inhibition of tissue culture cells treated with quinacrine
hydrochloride. Life Sci II. 1970 Sep 22;9(18):1061-9. PubMed PMID:
5478102.
331: Nieper HA. [Cytostatic effect of resochin and atebrin (compare same
journal 20 (N.F.) 28: 1591 (1969))]. Med Welt. 1970 May 30;22:1047-8.
German. PubMed PMID: 5509757.
332: Hickman JA, Jones MC. Treatment of neoplastic pleural effusions
with local instillations of quinacrine (mepacrine) hydrochloride.
Thorax. 1970 Mar;25(2):226-9. PubMed PMID: 5441993; PubMed Central
PMCID: PMC472150.
333: Cenedella RJ, Saxe LH, Van Dyke K. An automated method of mass drug
testing applied to screening for antimalarial activity. Chemotherapy.
1970 Mar;15(3):158-76. PubMed PMID: 5428024.
334: Hiller RI. A study of quinacrine dihyochloride in the human breast
in vitro and in vivo. Am J Surg. 1970 Mar;119(3):317-21. PubMed PMID:
4910325.
335: Montanari GD, Grismondi GL. [Intravital fluorescence of carcinoma
of the cervix uteri induced by quinacrine]. Minerva Ginecol. 1970 Feb
15;22(3):188-91. Italian. PubMed PMID: 5446694.
336: Bach MK. Reduction in the frequency of mutation to resistance to
cytarabine in L1210 murine leukemic cells by treatment with quinacrine
hydrochloride. Cancer Res. 1969 Oct;29(10):1881-5. PubMed PMID: 5823955.
337: Schmidt D, Haym J. [On the problem of a selective
thermosensitization of carcinoma cells in vivo with vitamin K3-sodium
bisulfite, methylene blue and other thermosensitizers. 2. Studies of an
effect of hyperthermia and in-vitro-thermosensitizers on the Yoshida-
and Jensen-sarcoma of rat]. Arzneimittelforschung. 1968 Jul;18(7):821-4.
German. PubMed PMID: 5755827.
338: von Ardenne M, Reitnauer PG. [Thermosensitization of mouse Ehrlich
ascites tumor cells using atebrin]. Dtsch Gesundheitsw. 1968 Feb
8;23(6):258-61. German. PubMed PMID: 5679078.
339: Fishbone PA, Ackerman NB. The increased uptake of quinacrine by
tumors in experimental animals: measurements of tissue levels by
fluorometric technique. Surg Forum. 1968;19:72-4. PubMed PMID: 5718421.
340: Bastos AL, Vigário JD, Moura Nunes JF, Nunes Petisca JL, Terrinha
AM. Preservation of acridine orange fluorescence and metachromasy of
tumor cells and cell cultures exposed to quinacrine. Acta Cytol. 1968
Jan-Feb;12(1):57-60. PubMed PMID: 4171418.
341: Witte S. Intravital fluorescent staining with acridine derivatives
in cytodiagnosis of the upper gastrointestinal tract. Acta Cytol. 1968
Jan-Feb;12(1):15-7. PubMed PMID: 4171416.
342: Borda I, Krant M. Convulsions following intrapleural administration
of quinacrine hydrochloride. JAMA. 1967 Sep 25;201(13):1049-50. PubMed
PMID: 6072485.
343: Dollinger MR, Krakoff IH, Karnofsky DA. Quinacrine (Atabrine) in
the treatment of neoplastic effusions. Ann Intern Med. 1967
Feb;66(2):249-57. PubMed PMID: 6016539.
344: Fekete I, Serfözö JI. [Metabolism of glucose, fructose, and mannose
in Ehrlich ascites carcinoma cells]. Naturwissenschaften. 1966
Oct;53(20):530-1. German. PubMed PMID: 5989295.
345: Anghileri LJ. Uptake of iodine-131-labelled atabrine by Ehrlich
ascites tumour and by sarcoma S-180 BALB. Nature. 1966 Aug
20;211(5051):878. PubMed PMID: 5968778.
346: Rigby PG. The leukocyte response to intraperitoneal Ehrlich ascites
tumor in mice. Proc Soc Exp Biol Med. 1966 Aug-Sep;122(4):996-1001.
PubMed PMID: 5918165.
347: Bastos AL. Intravital fluorescence in tumor cells. Acta Cytol. 1966
May-Jun;10(3):187-90. PubMed PMID: 5227369.
348: Lopatin AI. [The treatment of warts by acriquine in children].
Pediatriia. 1966 Apr;45(4):71-2. Russian. PubMed PMID: 5985087.
349: An agent for the palliative treatment of neoplastic effusions.
Quinacrine (atabrine) hydrochloride. JAMA. 1966 Mar 28;195(13):1139.
PubMed PMID: 4159922.
350: Budak VIa. [The treatment of common warts with injection of a 4
percent solution of quinacrine]. Vestn Dermatol Venerol. 1966
Mar;40(3):71-2. Russian. PubMed PMID: 5988251.
351: Frick HC 2nd, Atchoo N, Adamsons K Jr, Taylor HC Jr. The efficacy
of chemotherapeutic agents in the management of disseminated gynecologic
cancer. Am J Obstet Gynecol. 1965 Dec 15;93(8):1112-21. PubMed PMID:
5847906.
352: Anghileri LJ. Uptake of radioiodine labeled atabrine by enlarged
spleen in leukemic mice. J Nucl Med. 1965 Aug;6(8):594-7. PubMed PMID:
5831329.
353: YOUNG JM, WILD F, SIMON-REUSS I. STUDIES OF THE UPTAKE OF TRITIUM
LABELLED MEPACRINE BY TUMOURS. Br J Cancer. 1965 Jun;19:370-8. PubMed
PMID: 14316214; PubMed Central PMCID: PMC2071367.
354: ACKERMAN NB, HALDORSEN DK, WALLACE DL, MADSEN AJ, MCFEE AS.
AMINOACRIDINE UPTAKE BY EXPERIMENTAL TUMORS. JAMA. 1965 Jan
11;191:103-4. PubMed PMID: 14233225.
355: WOLF J. NEW TOOLS FOR LUNG CANCER? Arch Environ Health. 1964
Aug;9:141. PubMed PMID: 14155046.
356: RIGBY PG, HANSON TA, SMITH RS. PASSAGE OF LEUKEMIC CELLS ACROSS THE
PLACENTA. N Engl J Med. 1964 Jul 16;271:124-7. PubMed PMID: 14148236.
357: DOAN CA. APLASTIC VERSUS HYPERPLASTIC BLOOD DYSCRASIAS. Postgrad
Med. 1964 Jun;35:564-70. PubMed PMID: 14143297.
358: ROCHLIN DB, SMART CR, WAGNER DE, SILVA AR. THE CONTROL OF RECURRENT
MALIGNANT EFFUSIONS USING QUINACRINE HYDROCHLORIDE. Surg Gynecol Obstet.
1964 May;118:991-4. PubMed PMID: 14143468.
359: ACKERMAN NB, SHEMESH A. LOCALIZATION OF AMINOACRIDINE FLUORESCENCE
IN LUNG TUMORS OF RATS. JAMA. 1964 Mar 14;187:832-3. PubMed PMID:
14094322.
360: KARNOFSKY DA. CANCER CHEMOTHERAPEUTIC AGENTS. CA Cancer J Clin.
1964 Mar-Apr;14:67-72. PubMed PMID: 14129472.
361: MCKIBBIN B, GAZET J, HOPPE E, SCHWAB C. CHEMICAL IRRIGATION OF
WOUNDS INOCULATED WITH CANCER CELLS. Arch Surg. 1963 Nov;87:877-80.
PubMed PMID: 14058858.
362: ULTMANN JE, GELLHORN A, OSNOS M, HIRSCHBERG E. The effect of
quinacrine on neoplastic effusions and certain of their enzymes. Cancer.
1963 Mar;16:283-8. PubMed PMID: 13995323.
363: ZHARKOV VP. [Treatment of warts with acrichine.]. Zdravookhranenie
Kazakhstana. 1962;22(10):68-9. Russian. PubMed PMID: 14003521.
364: GELLHORN A, ZAIDENWEBER J, ULTMANN J, HIRSCHBERG E. The use of
atabrine (quinacrine) in the control of recurrent neoplastic effusions.
A preliminary report. Dis Chest. 1961 Feb;39:165-76. PubMed PMID:
13704297.
365: WIENER E, ACEL H. [A new contribution to the treatment of advanced
inoperable carcinoma: preliminary report.]. Z Gesamte Inn Med. 1959 Jun
1;14:544-5. German. PubMed PMID: 13844631.
366: MASCITELLI-CORIANDOLI E, BOLDRINI R, CITTERIO C. Not Available. Z
Naturforsch B. 1958 Jul;13b(7):468-9. English, German. PubMed PMID:
13593647.
367: REUSS A, LINDNER D. [Can the photometric determination of urinary
atebrin excretion be used in the early diagnosis of cancer.]. Arch
Geschwulstforsch. 1958;12(2-3):133-44. German. PubMed PMID: 13534327.
368: VASSEY JW, EDMONDS J, IRVIN JL, GREEN JA, IRVIN EM. Studies on the
administration of quinacrine to tumor-bearing mice. Cancer Res. 1955
Oct;15(9):573-8. PubMed PMID: 13261076.
369: BRILMAYER C, KUGEL E, MACK A. [Chromophile property of lung tissue
towards atebrin with special reference to malignant neoplasms.]. Arztl
Forsch. 1955 Aug 10;9(8):I/353-7. German. PubMed PMID: 13258395.
370: BINGOLD K, BRILMAYER C, MACK A. [Atebrin secretion in urine in
diagnosis of malignant tumors.]. Krebsarzt. 1955 Feb;10(1):1-12. German.
PubMed PMID: 14392900.
371: BRILMAYER C, KOHLER A, MACK A, STORDEUR K. [Affinity of certain
dyes for healthy and neoplastic tissue proved by quantitative tissue
extractions.]. Z Krebsforsch. 1955;60(3):334-43. German. PubMed PMID:
14386973.
372: LOCATELLI A. [Combined action of an acridine preparation and
colchicine on the growth of a transplantable tumor.]. Tumori. 1955
Jan-Feb;41(1):123-6. Italian. PubMed PMID: 14374014.
373: ADERHOLD K. [Determination of chromium fluoride excretion in urine
after intravenous atabrine administrations as method of early and
differential diagnosis of malignant tumors.]. Zentralbl Chir.
1953;78(30):1282-7. Undetermined Language. PubMed PMID: 13091220.
374: SAWICKY HH, KANOF NB, SILVERBERG MG, BRAITMAN M, KALISH B.
Therapeutic assays of the Skin and Cancer Unit of the New York
University Hospital. Assay VII-Quinacrine hydrochloride (atabrine
hydrochloride) for chronic discoid lupus erythematosus. J Invest
Dermatol. 1952 Dec;19(6):397-404. PubMed PMID: 13023012.
375: RUMSFELD HW Jr, CLAYTON CC, BAUMANN CA. Effects of atabrine and of
certain related substances on the development of liver tumors due to azo
dyes. Cancer Res. 1952 Sep;12(9):671-6. PubMed PMID: 12978999.
376: CRAMER H, BRILMAYER C. [Diagnosis of tumors with atebrin.]. Munch
Med Wochenschr. 1952 Aug 15;94(33-34):1641-6. Undetermined Language.
PubMed PMID: 12993014.
377: CRAMER VH, BRILMAYER C, PABST HW. [Diagnosis of tumors by selective
concentration of radioactive phosphorus, fluorides and atabrine.].
Schweiz Med Wochenschr. 1952 Jan 26;82(4):76-8. Undetermined Language.
PubMed PMID: 14930693.
378: SCHUTZE R. [Ultraviolet radiation and atebrin, diagnostic means in
tumor operations.]. Strahlentherapie. 1952;88(3-4):520-1. Undetermined
Language. PubMed PMID: 12995201.
379: SCHUTZE R, KLAR E. [Vital fluorochromatization of brain tumors with
atabrin as a diagnostic aid in brain tumor surgery.]. Chirurg. 1951
Apr;22(4):166-9. Undetermined Language. PubMed PMID: 14822110.
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|